scPharmaceuticals Inc expected to post a loss of 44 cents a share - Earnings Preview
06/05/2024 12:23
* scPharmaceuticals Inc SCPH.OQ SCPH.O is expected
to show a
rise in quarterly revenue when it reports results on May 8
(estimated) for the period ending March 31 2024
* The Burlington Massachusetts-based company is expected to
report a 189.7% increase in revenue to $5.977 million from $2.06
million a year ago, according to the mean estimate from 6
analysts, based on LSEG data.
* LSEG's mean analyst estimate for scPharmaceuticals Inc is
for a
loss of 44 cents per share.
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 6 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for
scPharmaceuticals
Inc is $19.00, above its last closing price of $4.66.
Previous quarterly performance (using preferred earnings measure
in US dollars).
QUARTER STARMINESM LSEG IBES ACTUAL BEAT, SURPRI
ENDING ARTESTIMAT ESTIMATE MET, SE %
E® MISSED
Dec. 31 2023 -0.52 -0.42 -0.35 Beat 16.4
Jan. 1 2023 -0.37 -0.36 -0.41 Missed -12.4
Jun. 30 2023 -0.37 -0.37 -0.36 Beat 3.3
Mar. 31 2023 -0.39 -0.36 -0.30 Beat 17.8
Dec. -0.34 -0.39 -0.30 Beat 22.5
31 2022
Sep. 30 2022 -0.36 -0.38 -0.37 Beat 3.3
Jun. 30 2022 -0.30 -0.30 -0.35 Missed -15.4
Mar. 31 2022 -0.32 -0.31 -0.28 Beat 9.7
This summary was machine generated May 6 at 11:23 GMT. All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)